Search Results
May 08, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
advance our CoMira joint venture, with today's lease finalization marking an important milestone in expanding our presence in the KSA," said Dwight Egan, Chief Executive Officer of Co-Diagnostics. "Executing the lease moves us from planning into the execution phase of development and reflects ongoing
More news about: Co-Diagnostics
May 08, 2026, 07:00 ET Enbridge Reports Strong First Quarter Results, Reaffirms 2026 Financial Guidance, and Grows Secured Backlog to $40 Billion
ancillary support infrastructure, supporting Enbridge's integrated storage platform in the region along with the previously sanctioned expansions at both Egan and Moss Bluff. New capacity is expected to enter service ratably from 2028 to 2030.Gas Transmission: Vector PipelineEnbridge has
More news about: Enbridge Inc.
May 08, 2026, 07:00 ET Enbridge Reports Strong First Quarter Results, Reaffirms 2026 Financial Guidance, and Grows Secured Backlog to $40 Billion
ancillary support infrastructure, supporting Enbridge's integrated storage platform in the region along with the previously sanctioned expansions at both Egan and Moss Bluff. New capacity is expected to enter service ratably from 2028 to 2030.Gas Transmission: Vector PipelineEnbridge has
More news about: Enbridge Inc.
May 07, 2026, 08:43 ET Per Scholas Launches First-Ever Critical Infrastructure Training Cohort in Collaboration with Microsoft to Build the Next Generation of Data Center Talent
confidence to contribute on day one.""The expansion of AI and cloud infrastructure is transforming how we think about workforce readiness," said Mike Egan, General Manager, Microsoft TechSpark. "By working with Per Scholas to co-design this program, we're helping ensure students are equipped with the skills
More news about: Per Scholas
May 07, 2026, 07:42 ET FACE Africa Appoints Former NBA Player Malcolm Brogdon, Victoria Brogdon and Maria Weaver to Board of Directors
act."Looking ahead, Pauline Egan, who became Executive Director of FACE Africa in late 2024, said the appointments come at a pivotal moment for the organization. "At FACE Africa, we take a holistic, locally led, and women-centered approach to sustainable development," said Egan. "We are intentional
More news about: FACE Africa
Apr 30, 2026, 15:22 ET EB Medicine Announces Daniel Egan, MD, as Editor-in-Chief of Emergency Medicine Practice
announced that Daniel Egan, MD, has been named Editor-in-Chief of of Emergency Medicine Practice.A longtime contributor to EB Medicine and a nationally recognized leader in emergency medicine education, Dr. Egan officially assumed editorial leadership on January 1.Dr. Egan succeeds Andy
More news about: EB Medicine
Apr 30, 2026, 13:59 ET Egan-Jones Recommends WEX Shareholders Support Impactive Nominees in 2026 Director Election
compensation peer groups that Egan-Jones believes obscure true performance. In Egan-Jones' view, the Impactive nominees would bring stronger operational, banking, regulatory, and shareholder alignment expertise to the Board.About Egan-Jones Proxy ServicesEgan-Jones Proxy Services provides
More news about: Egan-Jones Ratings Company
Apr 30, 2026, 09:00 ET Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
More news about: Co-Diagnostics
Apr 17, 2026, 11:07 ET Egan-Jones Recommends Ingles Markets Shareholders Support Rory A. Held to Improve Capital Allocation and Growth Oversight
million. Egan-Jones argues that shareholders would be best served by a rigorous evaluation of how this capital can be deployed to generate outsized returns.The Company has stagnated for years, with no new store openings and a significant portion of its real estate sitting idle. Egan-Jones concludes
More news about: Egan-Jones Ratings Company
Apr 16, 2026, 09:00 ET Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
recently-announced guidance from the World Health Organization related to near-point-of-care molecular diagnostics and easy-to-collect tongue swabs," said Dwight Egan, CEO of Co-Diagnostics. "We believe this is a timely opportunity to present the platform to representatives from so many other global stakeholders at
More news about: Co-Diagnostics
Apr 15, 2026, 07:00 ET Egan-Jones Appoints Sylvain Raynes, Ph.D., to Lead Structured Finance
leading industry texts."Sylvain brings a rare combination of technical depth, market experience, and analytical discipline," said Sean Egan, CEO and founder of Egan-Jones Ratings Company. "As structured finance markets continue to grow in scale and complexity, investors require independent, transparent
More news about: Egan-Jones Ratings Co.
Apr 14, 2026, 13:00 ET Egan-Jones Releases April 2026 CLO Market Summary
SOFR were 1.3% and 3.4%, respectively. The report also states that Egan-Jones currently tends to have a more positive view of CLO credit quality than other credit rating agencies.About Egan-Jones RatingsEgan-Jones, an NRSRO founded in 1995, offers timely and accurate credit ratings
More news about: Egan-Jones Ratings Company
Apr 09, 2026, 13:00 ET Egan-Jones Analysis Supports Continuity at Peoples Financial Corporation
that a radical turnaround is needed at the bank." Egan-Jones therefore recommends that shareholders WITHHOLD votes from the Stilwell nominee Stewart Peck and vote FOR all six management nominees.About Egan-Jones Proxy ServicesEgan-Jones Proxy Services provides independent proxy voting
More news about: Egan-Jones Ratings Company
Apr 09, 2026, 09:00 ET Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
"Switzerland and Germany are home to many of the world's leading technology, diagnostics, financial and R&D environments," said Dwight Egan, Chief Executive Officer, Co-Diagnostics, Inc. "We are pleased to be part of this prestigious trade mission and to help further the goals of our community,
More news about: Co-Diagnostics
Apr 02, 2026, 09:00 ET Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
Co-Dx PCR platform*, and is expected to support our international expansion objectives across the Middle East and Northern Africa," remarked Dwight Egan, CEO of Co-Diagnostics.The allocated site is intended to support, subject to further development activities and approvals, the development of
More news about: Co-Diagnostics
Mar 31, 2026, 16:01 ET Co-Diagnostics Reports Full Year 2025 Financial Results
including advancing our clinical pipeline, expanding our global footprint, and preparing for commercialization of the platform in 2026," said Dwight Egan, Chief Executive Officer of Co-Diagnostics. "Importantly, we have remained focused on execution and continued to build momentum across the business.
More news about: Co-Diagnostics
Mar 25, 2026, 08:00 ET Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization
diagnostic gaps.The Company's PCR testing platform* and NPOC TB test kit are already aligned with this new guidance.Co-Diagnostics CEO Dwight Egan remarked, "We are pleased that our foresight in designing the Co-Dx PCR testing platform and TB test for broad accessibility in point-of-care and near-point-of-care
More news about: Co-Diagnostics
Mar 24, 2026, 19:01 ET Egan-Jones Comments on SEC Order Denying Its Application for Exemptive Relief
one-time event. At issue is a November 2025 request by an Egan-Jones client that Egan-Jones issue an unexpected number of ratings late in 2025. The effect of the issuance of the requested ratings, given the size of Egan-Jones, would have caused Egan-Jones to exceed the regulatory 10% threshold. The one-time
More news about: Egan-Jones Ratings Company
Mar 23, 2026, 23:43 ET Egan-Jones Responds to SEC Order for Formal Review of Application to Resume Rating of Issuers of Asset-Backed Securities and Government Securities
Sean Egan, co-founder and CEO of Egan-Jones, stated, "This is the SEC process, and we will provide all information necessary to support our application to resume rating these two classes of issuers of securities. Egan-Jones has made great strides in our internal
More news about: Egan-Jones Ratings Company
Mar 20, 2026, 08:00 ET Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
across these markets, increasing access to molecular tests for tuberculosis, HPV, and upper respiratory infections."Co-Diagnostics CEO Dwight Egan added, "This expansion reflects our broader strategy of establishing regional infrastructure ahead of product commercialization. By building local manufacturing
More news about: Co-Diagnostics
Mar 19, 2026, 13:00 ET Egan-Jones Releases Commentary on Conflicts of Interest in the Corporate Governance Industry
comfort to investors and would benefit from a reorganization designed to strengthen oversight and reduce conflicts.About Egan-Jones Proxy ServicesEgan-Jones Proxy Services provides independent proxy-voting analysis, recommendations, and reporting for institutional investors.Media
More news about: Egan-Jones Ratings Company
Mar 17, 2026, 13:00 ET Egan-Jones Releases Risk Commentary on Military Technology Shifts and Iran Related Investment Risks
should carefully assess how evolving military capabilities may affect global stability and investment environments.About Egan-Jones RatingsEgan-Jones, an NRSRO founded in 1995, offers timely and accurate credit ratings and proxy services.Media Contact:
More news about: Egan-Jones Ratings Company
Mar 17, 2026, 09:00 ET Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.
More news about: Co-Diagnostics
Mar 12, 2026, 13:00 ET Egan-Jones Proxy Highlights Shareholder Dissatisfaction at Jack in the Box Annual Meeting
companies.According to the report, directors that Egan-Jones recommended against received significantly lower levels of support, suggesting that investors shared concerns regarding company performance and board oversight.The analysis also highlights Egan-Jones' independent structure as a proxy advisory
More news about: Egan-Jones Ratings Company
Mar 12, 2026, 09:00 ET Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
single application."The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process," said Dwight Egan, Chief Executive Officer of Co-Diagnostics. "We believe that receiving such a comprehensive patent by the JPO illustrates the uniqueness and innovation
More news about: Co-Diagnostics